Similar articles for PMID: 15579793

Year	Number of Results
1963	1
1970	1
1974	1
1976	1
1977	1
1979	1
1981	1
1982	1
1983	2
1984	2
1985	2
1986	1
1987	4
1988	3
1989	2
1990	1
1991	1
1992	4
1993	7
1994	2
1995	3
1996	7
1997	3
1998	10
1999	5
2000	3
2001	4
2002	7
2003	10
2004	10
2005	9
2006	12
2007	7
2008	6
2009	9
2010	14
2011	9
2012	6
2013	7
2014	8
2015	10
2016	12
2017	6
2018	5
2019	8
2020	2
2021	2
2022	2
2023	4
2024	0

1

Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility.

Balen AH, Mulders AG, Fauser BC, Schoot BC, Renier MA, Devroey P, Struijs MJ, Mannaerts BM. Balen AH, et al. J Clin Endocrinol Metab. 2004 Dec;89(12):6297-304. doi: 10.1210/jc.2004-0668. J Clin Endocrinol Metab. 2004. PMID: 15579793 Clinical Trial.

2

Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.

Devroey P, Fauser BC, Platteau P, Beckers NG, Dhont M, Mannaerts BM. Devroey P, et al. J Clin Endocrinol Metab. 2004 May;89(5):2062-70. doi: 10.1210/jc.2003-031766. J Clin Endocrinol Metab. 2004. PMID: 15126522 Clinical Trial.

3

Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.

Fauser BC, Alper MM, Ledger W, Schoolcraft WB, Zandvliet A, Mannaerts BM; Engage Investigators. Fauser BC, et al. Reprod Biomed Online. 2010 Nov;21(5):593-601. doi: 10.1016/j.rbmo.2010.06.032. Epub 2010 Jun 30. Reprod Biomed Online. 2010. PMID: 20843746 Clinical Trial.

4

Corifollitropin alfa compared with follitropin beta in poor responders undergoing ICSI: a randomized controlled trial.

Kolibianakis EM, Venetis CA, Bosdou JK, Zepiridis L, Chatzimeletiou K, Makedos A, Masouridou S, Triantafillidis S, Mitsoli A, Tarlatzis BC. Kolibianakis EM, et al. Hum Reprod. 2015 Feb;30(2):432-40. doi: 10.1093/humrep/deu301. Epub 2014 Dec 9. Hum Reprod. 2015. PMID: 25492411 Clinical Trial.

5

Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study.

Hugues JN, Soussis J, Calderon I, Balasch J, Anderson RA, Romeu A; Recombinant LH Study Group. Hugues JN, et al. Hum Reprod. 2005 Mar;20(3):629-35. doi: 10.1093/humrep/deh682. Epub 2004 Dec 23. Hum Reprod. 2005. PMID: 15618252 Clinical Trial.

6

The use of a decremental dose regimen in patients treated with a chronic low-dose step-up protocol for WHO Group II anovulation: a prospective randomized multicentre study.

Hugues JN, Cédrin-Durnerin I, Howles CM; FSH OI Study Group; Amram M, Angelini A, Balen A, Barbereau D, Birkhauser M, Boujenah A, De Leo V, De Placido G, Dessole S, Favrin S, Ferrazi E, Gay C, Germond M, Hedon B, Hocke C, Jolly C, Lamarca-Roth E, Lanzone A, Marchand F, Marcolin G, Mascaretti G, Moreau L, Massobrio M, Nappi C, Pardi G, Pennehouat G, Porcu E, Seibert M, Selvaggi L, Thiers D, Venturini P. Hugues JN, et al. Hum Reprod. 2006 Nov;21(11):2817-22. doi: 10.1093/humrep/del265. Epub 2006 Jul 27. Hum Reprod. 2006. PMID: 16877376 Free article. Clinical Trial.

7

Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females.

Duijkers IJ, Klipping C, Boerrigter PJ, Machielsen CS, De Bie JJ, Voortman G. Duijkers IJ, et al. Hum Reprod. 2002 Aug;17(8):1987-93. doi: 10.1093/humrep/17.8.1987. Hum Reprod. 2002. PMID: 12151425

8

Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. The European Recombinant Human LH Study Group.

[No authors listed] [No authors listed] J Clin Endocrinol Metab. 1998 May;83(5):1507-14. doi: 10.1210/jcem.83.5.4770. J Clin Endocrinol Metab. 1998. PMID: 9589647 Clinical Trial.

9

Follicular characteristics and luteal development after follicle-stimulating hormone induced multiple ovulations in heifers.

Glick G, Hogeg M, Moallem U, Lavon Y, Wolfenson D. Glick G, et al. J Anim Sci. 2013 Jan;91(1):188-94. doi: 10.2527/jas.2012-5536. Epub 2012 Oct 24. J Anim Sci. 2013. PMID: 23097398 Clinical Trial.

10

The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.

Schipper I, Hop WC, Fauser BC. Schipper I, et al. J Clin Endocrinol Metab. 1998 Apr;83(4):1292-8. doi: 10.1210/jcem.83.4.4710. J Clin Endocrinol Metab. 1998. PMID: 9543158 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

219 results

Results by year